Archive · 21 Nov 2025
Sudeep Pharma IPO Strongly Subscribed on Day 1
Sudeep Pharma's initial public offering (IPO) had a great start on its first day.
Many people wanted to buy shares, especially non-institutional investors and regular people.
The shares are also being bought and sold in the 'grey market' for more than the highest price they can be bought for in the IPO.
The company will use the money it gets from selling shares to buy new machines and for other general purposes.
Sudeep Pharma IPO received 1.42 times bids on Day 1
Non-institutional investors and retail investors led the subscription
Grey market premium (GMP) stood at ₹111, signaling 19% listing pop
IPO worth ₹895 crore priced at ₹563-593 per share
Proceeds to be used for capital expenditure and general corporate purposes
- Who
- Sudeep Pharma
- What
- Having Initial Public Offering (IPO)
- When
- November 21, 2025
- Where
- Stock exchanges (NSE and BSE)
- Why
- To raise funds for business expansion and upgrades
Positive on Sudeep Pharma's Growth
Cautious on Sudeep Pharma's Valuation
Global Pharma Market
Positive on Sudeep Pharma's Growth
Strong demand and growth opportunities
Cautious on Sudeep Pharma's Valuation
Valuation appears fully priced
- IPO Size
- ₹895 crore
- IPO Subscription Status
- 1.42x
- IPO Price Band
- ₹563-₹593
- Grey Market Premium (GMP)
- ₹111
- Listing Date
- November 28, 2025
- Proceeds Allocation
- Capital expenditure and general corporate purposes
Sources
Excelsoft Technologies IPO sees stellar demand, subscribed 23.45x so far on final day; Sudeep Pharma IPO nears full subscription on Day 1
Excelsoft Technologies IPO Closes Today: Price Band, GMP, Subscription, Allotment & Listing Details
Sudeep Pharma IPO sails through on first day amid NII, retail demand; GMP signals 19% listing pop
